U.S. Markets open in 45 hrs, 22 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 43.01 09:40 AM EDT | |
|---|---|---|
| Day High | 43.50 01:42 PM EDT |
|
| Range | 0.49 |
| Volume | 879,702 | |
|---|---|---|
| 30-Day Avg Vol | 1.25 M |
|
| Difference | -29.62% |
| Market Cap | 62.55 B | |
|---|---|---|
| Mkt Cap Chg | -2.05 B |
| Shares Out | 1.44 B | |
|---|---|---|
| % Shrs Traded | 0.06% | |
| 1yr EPS Est | 5.415 |
| 52-Wk Low | 29.96 3/9/09 | |
|---|---|---|
| 52-Wk High | 49.85 8/5/08 |
|
| Range | 19.89 |
| Prev Close | 44.63 7/1/09 | |
|---|---|---|
| Today's Open | 43.32 | |
| Change | -2.94% |
| Dividend (TTM) | 2.05 | |
|---|---|---|
| Div Yield (TTM) | 4.64% | |
| Ex-Div Date | 02/04/2009 | |
| Div Date | 03/16/2009 |
|
| Short Interest | 3.93 M |
| Revenue (LFY) | 31.60 B | |
|---|---|---|
| Earnings (LFY) | 6.10 B | |
| Earnings (MRQ) | 1.81 B | |
| Next Earn Est | 1.38 | |
| Next Earnings | 10/29/2009 |
|
| EPS (TTM) | 4.26829 | |
| 1yr EPS Growth | 0.28% |
| P/E Ratio (TTM) | 10.29 | |
|---|---|---|
| P/E Ratio (Fwd) | 7.90 | |
| PEG Ratio | -3.59 | |
| Return on Equity | 39.74 | |
| Beta | 0.64 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
AstraZeneca's products run the gamut from A (breast cancer drug Arimidex) to Z (migraine treatment Zomig). One of the world's top pharmaceutical firms, AstraZeneca specializes in drugs for gastrointestinal, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 1.38 7/30/09 | — — |
—
—
|
| Last Quarter | 1.403 3/31/09 | 1.58 3/31/09 |
0.177
Beat
|
| 2 Quarters Ago | 1.165 12/31/08 | 1.25 12/31/08 |
0.085
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 6.49 B | 31.60 B |
| Gross Profit | 5.35 B | 24.88 B |
| Operating Income | 2.50 B | 10.02 B |
| Net Income | 1.81 B | 6.10 B |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts